MicroRNA‐340‐5p increases telomere length by targeting telomere protein POT1 to improve Alzheimer's disease in mice
Authors:
- 24 February 2021
- journal article
- research article
- Published by Wiley in Cell Biology International
- Vol. 45 (6) , 1306-1315
Abstract
Alzheimer′s disease (AD) is a chronic neurodegenerative disorder which is the primary cause of dementia in the elderly. Telomere attrition has been proposed as a hallmark of aging. Our study aimed to explore the mechanism of the protection of telomere 1 (POT1) in regulating telomere length and affecting cellular senescence in AD. The AD mouse model was established by d‐galactose and aluminum chloride, and the water maze test and dark avoidance test were used to detect the behaviors of mice and confirm the success of AD mouse model. AD cell model was established with HT22 cells induced by Aβ42 oligomers. POT1 expression in the AD model was detected by quantitative real‐time polymerase chain reaction. Cellular telomere length in hippocampal tissue was analyzed by telomere restriction fragment. Localization of intracellular POT1, telomerase, and telomeres was analyzed by immunofluorescence and fluorescence in situ hybridization. Dual‐luciferase assay was used to validate the targeted binding relationship between microRNA‐340‐5p (miR‐340‐5p) and POT1. After inhibiting POT1 expression, the symptoms of AD in mice were improved. Aβ1–42 deposition was reduced, whereas telomere length and telomerase activity was increased. Dual‐luciferase assay verified the binding relationship between miR‐340‐5p and POT1. An increase in miR‐340‐5p expression could alleviate cellular senescence and AD symptoms. miR‐340‐5p increased cellular telomere length and delayed cell senescence by inhibiting POT1 expression to improve AD symptoms. This study made a conclusion that miR‐340‐5p increased cellular telomere length and delayed cell senescence by inhibiting POT1 expression to improve AD symptoms in mice.Keywords
This publication has 29 references indexed in Scilit:
- The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer’s diseaseMolecular Brain, 2015
- Complex interactions between the DNA-damage response and mammalian telomeresNature Structural & Molecular Biology, 2015
- Predicting effective microRNA target sites in mammalian mRNAseLife, 2015
- Telomerase abrogates aneuploidy‐induced telomere replication stress, senescence and cell depletionThe EMBO Journal, 2015
- starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq dataNucleic Acids Research, 2013
- A mutation in APP protects against Alzheimer’s disease and age-related cognitive declineNature, 2012
- Amyloid β accelerates phosphorylation of tau and neurofibrillary tangle formation in an amyloid precursor protein and tau double‐transgenic mouse modelJournal of Neuroscience Research, 2010
- Functional Diversity of Human Protection of Telomeres 1 Isoforms in Telomere Protection and Cellular SenescenceCancer Research, 2007
- Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1Nature, 2007
- POT1 as a terminal transducer of TRF1 telomere length controlNature, 2003